MECOM and breast cancer: Most of these genes were associated with cancers of metabolic systems (DUSP6, SGK1, BMP4, RASGRF1, GDF15) followed by breast cancer (CACNA2D3, ITGB7), cancers of the central nervous system (PRKCA), or leukemia (MECOM, JAK3).